DK0910428T3 - Fotoferesebehandling af kroniske HCV-infektioner - Google Patents

Fotoferesebehandling af kroniske HCV-infektioner

Info

Publication number
DK0910428T3
DK0910428T3 DK97916965T DK97916965T DK0910428T3 DK 0910428 T3 DK0910428 T3 DK 0910428T3 DK 97916965 T DK97916965 T DK 97916965T DK 97916965 T DK97916965 T DK 97916965T DK 0910428 T3 DK0910428 T3 DK 0910428T3
Authority
DK
Denmark
Prior art keywords
chronic hcv
hcv infections
patient
treatment
photopheresis treatment
Prior art date
Application number
DK97916965T
Other languages
English (en)
Inventor
Susan N Mclaughlin
Bruce C Stouch
Christopher B O'brien
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Application granted granted Critical
Publication of DK0910428T3 publication Critical patent/DK0910428T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
DK97916965T 1996-03-29 1997-03-26 Fotoferesebehandling af kroniske HCV-infektioner DK0910428T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1461296P 1996-03-29 1996-03-29

Publications (1)

Publication Number Publication Date
DK0910428T3 true DK0910428T3 (da) 2006-02-13

Family

ID=21766536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97916965T DK0910428T3 (da) 1996-03-29 1997-03-26 Fotoferesebehandling af kroniske HCV-infektioner

Country Status (13)

Country Link
US (1) US20040062754A1 (da)
EP (1) EP0910428B1 (da)
JP (1) JP2000510003A (da)
CN (1) CN1214636A (da)
AT (1) ATE307634T1 (da)
AU (1) AU717624B2 (da)
BR (1) BR9708406A (da)
CA (1) CA2250920A1 (da)
DE (1) DE69734450T2 (da)
DK (1) DK0910428T3 (da)
ES (1) ES2251020T3 (da)
IL (1) IL126365A0 (da)
WO (1) WO1997036634A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
US6219584B1 (en) * 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
EP1469733A4 (en) 2001-11-29 2008-07-23 Therakos Inc METHODS FOR PRETREATING A SUBJECT USING EXTRACORPOREAL PHOTOPHERESIS AND / OR APOPTOTIC CELLS
US7186230B2 (en) 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
DE202004004263U1 (de) 2004-03-18 2004-05-19 Weber, Waldfried Bestrahlungsgerät für Blut
EP2443922B1 (en) 2005-11-02 2017-05-03 Therakos, Inc. The use of apoptotic cells ex vivo to generate regulatory T cells
MX2008014110A (es) 2006-05-02 2008-11-14 Therakos Inc Metodos y reactivos para detectar la susceptibilidad a la enfermedad del injerto versus el hospedero o mortalidad relacionada con el transplante.
ITVE20070005A1 (it) * 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
US10441810B2 (en) 2007-04-08 2019-10-15 Immunolight, Llc X-ray psoralen activated cancer therapy (X-PACT)
US9358292B2 (en) 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US10596387B2 (en) * 2007-04-08 2020-03-24 Immunolight, Llc. Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
WO2015164487A1 (en) * 2014-04-22 2015-10-29 Immunolight, Llc Interior energy-activation of photo-reactive species inside a medium or body using an x-ray source emitting low energy x-rays as initiation energy source
EP3365017A4 (en) * 2015-10-19 2019-04-17 Immunolight, LLC X-PACT ACTIVATED ANTI-CANCER TREATMENT BASED ON X-RAY-ACTIVATED PSORALENE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
AU6267596A (en) * 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
AU2453697A (en) * 1996-04-10 1997-10-29 Trustees Of The University Of Pennsylvania, The Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Also Published As

Publication number Publication date
CA2250920A1 (en) 1997-10-09
DE69734450T2 (de) 2006-08-10
JP2000510003A (ja) 2000-08-08
ES2251020T3 (es) 2006-04-16
AU717624B2 (en) 2000-03-30
ATE307634T1 (de) 2005-11-15
EP0910428A4 (en) 2001-03-28
EP0910428B1 (en) 2005-10-26
DE69734450D1 (de) 2005-12-01
US20040062754A1 (en) 2004-04-01
WO1997036634A1 (en) 1997-10-09
BR9708406A (pt) 2000-01-04
EP0910428A1 (en) 1999-04-28
CN1214636A (zh) 1999-04-21
IL126365A0 (en) 1999-05-09
AU2544197A (en) 1997-10-22

Similar Documents

Publication Publication Date Title
DK0910428T3 (da) Fotoferesebehandling af kroniske HCV-infektioner
BR9708468A (pt) Tratamento de fotoferese de leucocitos.
NZ309217A (en) Ribavirin and interferon alpha for the treatment of hepatitis C
ATE186460T1 (de) Methode zur verhinderung von restenosierung nach rekanalisierung von körpergefässen
MY133891A (en) Polyethylene glycol modified interferon therapy
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE68911061T2 (de) Mittel zur Kontrolle von Thrombenbildungen.
DE69902103D1 (de) Behandlung von hepatitis b mit thymosin alpha 1 und lamivudin
KR950701215A (ko) 편두통 치료방법(Treatment of migraine)
ES2069894T3 (es) Una preparacion anticoagulante.
DE69428112T2 (de) Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
RU98119730A (ru) Лечение с помощью фотофереза хронического гепатита с
RU92011195A (ru) Способ уменьшения дозы химиопрепаратов, используемых для лечения инфекционных заболеваний при одновременном повышении их терапевтической эффективности
UA28207A (uk) Спосіб лікування черепно-мозкової травми
RU92001489A (ru) Препарат для лечения инфекционного гепатита, способ получения препарата и способ лечения гепатита
UA11276C2 (uk) Спосіб реабілітації хворих, які переhесли вірусhий гепатит
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
UA33890A (uk) Спосіб лікування хвороби пейроні
UA29943A (uk) Спосіб лікування хворих на хронічний гепатит
RU94006959A (ru) Способ лечения мочекислого уролитиаза
RU92016457A (ru) Антикоагулирующий препарат